Preview: Apogee Therapeutics, Inc Set To IPO Tomorrow
Portfolio Pulse from Benzinga Insights
Apogee Therapeutics, Inc (NASDAQ:APGE) is set to IPO on July 14, with shares expected to be priced between $15.00 and $17.00. The company, which develops biologics for the treatment of AD, COPD, and related I&I indications, has an insider lock-up period of 180 days ending on January 10, 2024.
July 13, 2023 | 3:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Apogee Therapeutics, Inc's IPO could potentially attract investors interested in the biotechnology sector. The insider lock-up period could limit stock liquidity in the short term.
IPOs often attract investor attention and can lead to increased stock price volatility. The insider lock-up period could limit the availability of shares in the market, potentially leading to price increases if demand is high.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100